Literature DB >> 10864208

Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity.

B Liu1, M Fang, M Schmidt, Y Lu, J Mendelsohn, Z Fan.   

Abstract

We previously reported that exposure of DiFi human colon cancer cells to the anti-epidermal growth factor (EGF) receptor monoclonal antibody (mAb) 225 resulted in apoptosis, but the mechanisms remain to be elucidated. In the present study, we investigated the effects of a panel of four anti-EGF receptor mAbs, each of which binds to different epitopes of the EGF receptor in DiFi cells, on the induction of apoptosis. We found that each of these mAbs induced apoptosis in DiFi cells. Exposure of DiFi cells to mAb 225 activated the initiation caspase-8, which was detectable between 8 and 16 h after exposure of the cells to the antibody. There was also an activation of the initiation caspase-9, which lagged a few hours behind the activation of caspase-8. Exposure of DiFi cells to mAb 225 also activated the execution caspase-3, which was accompanied temporally by evidence of cleavage of a well-characterized caspase-3 substrate, poly(ADP)ribosepolymerase (PARP). Pre-exposure of the cells to the caspase-3-specific inhibitor DEVD-CHO partially reduced the mAb 225-induced PARP cleavage and apoptosis, whereas pre-exposure of the cells to the caspase pan-inhibitor z-VAD-fmk completely inhibited mAb 225-induced apoptosis. Caspases-3, -8 and -9 were not activated in the cell lines in which mAb 225 only induced G1 phase arrest of the cell cycle. In contrast to the apoptosis of DiFi cells induced by ultraviolet irradiation, which strongly activated the c-jun N-terminal kinase-1 (JNK1) and the caspase cascade, mAb 225-induced apoptosis and activation of the caspase cascade in DiFi cells were not associated with activation of JNK1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864208      PMCID: PMC2363248          DOI: 10.1054/bjoc.2000.1201

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  65 in total

1.  Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor.

Authors:  J L Chou; Z Fan; T DeBlasio; A Koff; N Rosen; J Mendelsohn
Journal:  Breast Cancer Res Treat       Date:  1999-06       Impact factor: 4.872

Review 2.  Therapeutic application of anti-growth factor receptor antibodies.

Authors:  Z Fan; J Mendelsohn
Journal:  Curr Opin Oncol       Date:  1998-01       Impact factor: 3.645

3.  Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization.

Authors:  E Bossy-Wetzel; D D Newmeyer; D R Green
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

4.  An induced proximity model for caspase-8 activation.

Authors:  M Muzio; B R Stockwell; H R Stennicke; G S Salvesen; V M Dixit
Journal:  J Biol Chem       Date:  1998-01-30       Impact factor: 5.157

Review 5.  Caspases: the executioners of apoptosis.

Authors:  G M Cohen
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

6.  Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225.

Authors:  D Ye; J Mendelsohn; Z Fan
Journal:  Oncogene       Date:  1999-01-21       Impact factor: 9.867

7.  Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis.

Authors:  X M Sun; M MacFarlane; J Zhuang; B B Wolf; D R Green; G M Cohen
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

8.  Human squamous cell lung cancers express increased epidermal growth factor receptors.

Authors:  F J Hendler; B W Ozanne
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.

Authors:  J D Sato; T Kawamoto; A D Le; J Mendelsohn; J Polikoff; G H Sato
Journal:  Mol Biol Med       Date:  1983-12

10.  Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity.

Authors:  G N Gill; T Kawamoto; C Cochet; A Le; J D Sato; H Masui; C McLeod; J Mendelsohn
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

View more
  29 in total

Review 1.  Understanding resistance to EGFR inhibitors-impact on future treatment strategies.

Authors:  Deric L Wheeler; Emily F Dunn; Paul M Harari
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

2.  Roles of autophagy in cetuximab-mediated cancer therapy against EGFR.

Authors:  Xinqun Li; Yang Lu; Tianhong Pan; Zhen Fan
Journal:  Autophagy       Date:  2010-11       Impact factor: 16.016

3.  [Immunotherapy of head and neck cancer. Identification of a novel mechanism for anti-EGFR mAb anti-tumor effects].

Authors:  T K Hoffmann
Journal:  HNO       Date:  2011-03       Impact factor: 1.284

4.  Recombinant chimeric antibody hCAb as a novel anti-human colorectal carcinoma agent.

Authors:  Hua Xiong; Ling Li; Qin-Chuan Liang; Hui-Jie Bian; Juan Tang; Qin Zhang; Li Mi; Zhi-Nan Chen
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

5.  Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion.

Authors:  Lulin Hu; Kendra Plafker; Valeriya Vorozhko; Rosemary E Zuna; Marie H Hanigan; Gary J Gorbsky; Scott M Plafker; Peter C Angeletti; Brian P Ceresa
Journal:  Virology       Date:  2008-11-28       Impact factor: 3.616

Review 6.  Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience.

Authors:  Pierpaolo Correale; Maria Grazia Cusi; Lucia Micheli; Cristina Nencini; Maria Teresa Del Vecchio; Francesco Torino; Angelo Aquino; Enzo Bonmassar; Guido Francini; Giorgio Giorgi
Journal:  Invest New Drugs       Date:  2006-03       Impact factor: 3.850

Review 7.  New approaches in angiogenic targeting for colorectal cancer.

Authors:  Aleix Prat; Esther Casado; Javier Cortés
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 8.  [Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy].

Authors:  T K Hoffmann; T L Whiteside; H Bier
Journal:  HNO       Date:  2005-03       Impact factor: 1.284

9.  Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cells.

Authors:  Bin-Wen Wu; Yuan Wu; Jia-Long Wang; Ju-Sheng Lin; Shu-Yu Yuan; Ai Li; Wu-Ren Cui
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

10.  Elucidation of apoptosis induced by serum deprivation in cultured conjunctival epithelial cells.

Authors:  A Higuchi; S Shimmura; T Takeuchi; M Suematsu; K Tsubota
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.